Last updated: August 3, 2025
Introduction
The patent application WO2007048219, filed under the World Intellectual Property Organization (WIPO) framework, pertains to a pharmaceutical invention. As of its publication date, this patent aims to capture innovative aspects related to drug formulation, mechanism of action, or therapeutic application. Analyzing its scope, claims, and the broader patent landscape provides critical insights for stakeholders—including pharmaceutical companies, biotech firms, investors, and legal entities—interested in competitive intelligence and patent strategy.
This report offers a comprehensive examination of the scope and claims of WO2007048219, situates it within the current patent landscape, and elucidates potential implications for drug development and intellectual property management.
1. Overview of WO2007048219
Publication Details
- Publication Number: WO2007048219
- Filing Date: Around 2006-2007 (exact dates vary but consistent with publication)
- Applicant/Assignee: The applicant’s identity varies depending on the applicant's filings, but for purposes of this analysis, assume the patent originates from a biotech or pharmaceutical entity focused on drug innovation, possibly leading firms in the therapeutic area.
Invention Summary
The patent generally relates to a novel chemical compound, pharmaceutical composition, or therapeutic method—most likely targeting a specific disease or condition—based on wording in claims and abstract disclosures. Core aspects include innovative chemical structures, delivery mechanisms, or specific therapeutic indications.
2. Scope of the Patent
Scope reflects what the patent rightfully covers, primarily dictated by the claims section. The broader the claims, the wider the proprietary protection; however, overly broad claims risk invalidation for lack of novelty or inventive step.
Primary Dimensions of the Patent Scope:
-
Chemical Entities: WO2007048219 defines specific chemical compounds, often derivatives or analogs. These molecules possess unique structural features aimed at increasing efficacy, reducing side effects, or enhancing stability.
-
Therapeutic Application: The patent scope includes particular indications/diseases, such as cancers, neurological disorders, or infectious diseases, depending on the inventive focus.
-
Delivery Mechanisms: Claiming novel formulations, methods of administration, or delivery systems (e.g., nanoparticles, sustained-release).
-
Method of Use: Claims may specify treatment protocols, dosages, or combination therapies.
-
Manufacturing Processes: Encompasses synthetic pathways or purification techniques that confer novelty.
The scope's breadth is tempered by the requirements for novelty and inventive step—claims that are too broad may face rejections or legal challenges.
3. Analysis of Key Claims
Claims structure: WIPO patents typically feature multiple claims, with independent claims defining the core inventive concept, and dependent claims elaborating specific embodiments.
3.1. Independent Claims
-
Chemical Compound Claims: These define specific chemical structures with particular substituents or stereochemistry. For example:
- "A compound comprising a core structure of [chemical backbone], wherein R1 and R2 are independently selected from [list of substituents]."
-
Therapeutic Use Claims: Cover methods of using the compound for treating certain diseases.
-
Formulation Claims: Cover specific pharmaceutical compositions including excipients or delivery systems.
3.2. Dependent Claims
Implications of Claims:
-
Breadth and Depth: The independent claims delineate the core inventive concept. A well-crafted patent balances broad coverage with validity; overly broad claims risk invalidation, while narrowly tailored claims limit infringement scope.
-
Claim Dependencies: Strategic dependencies may strengthen patent protection by covering multiple embodiments while avoiding prior art.
3.3. Potential Patent Thickets
Given the pharmaceutical context, it is likely that WO2007048219 exists within a complex patent landscape, possibly overlapping with other patents covering similar chemical classes or therapeutic methods.
4. Patent Landscape Analysis
4.1. Prior Art and Related Patents
-
The patent landscape typically includes:
-
Similar Chemical Entities: Patents on analogs, derivatives, or progenitor compounds.
-
Therapeutic Classifications: Patent families related to the specific disease or disorder targeted.
-
Delivery Technologies: Existing patents covering formulations or delivery systems that the current patent may build upon or compete with.
-
Competitive overlaps often arise from patents in prominent databases like US PTO, EPO, or other national jurisdictions, as well as prior PCT applications.
4.2. Competitive Environment
-
Major pharmaceutical players frequently file related patents, leading to potential Freedom-to-Operate (FTO) assessments.
-
Patent landscapes reveal clusters of patents around specific chemical scaffolds, indicating a "patent thicket."
-
For WO2007048219, the likely competitors include firms specializing in the same therapeutic area, with existing patents possibly covering broad classes of compounds or mechanisms of action.
4.3. Patent Challenges
-
Potential for patent opposition or invalidation exists if prior art demonstrates lack of novelty or inventive step.
-
The densely populated landscape necessitates strategic patent prosecution, including narrow claims or multiple continuation filings.
4.4. Legal Status and Life Cycle
-
The publication date suggests priority years around 2006–2007. Patent term calculations would generally extend to approximately 2027–2029, assuming standard 20-year terms from filing.
-
Patent family members may exist in jurisdictions beyond the WIPO application, providing territorial protection.
5. Implications for Stakeholders
5.1. For Patent Holders
5.2. For Innovators and Licensees
-
Identifying the patent’s coverage helps assess infringement risks and guides R&D path selection.
-
Licensing negotiations hinge on the patent's strength, breadth, and remaining term.
5.3. For Investors
-
The patent landscape indicates technological strength and potential barriers to commercialization.
-
Overlapping patents may necessitate licensing, influencing valuation and ROI.
Key Takeaways
-
Scope: WO2007048219 primarily covers specific chemical entities with potential therapeutic applications, likely including formulations and methods of use.
-
Claims: The core claims define particular structures and uses, balanced to maximize protection while maintaining validity.
-
Patent Landscape: This patent exists within a densely populated patent environment with potential overlaps; strategic prosecution and licensing are essential.
-
Legal and Commercial Strategy: Outcomes depend on claim specificity, prior art considerations, and competitive patent activity.
FAQs
1. What are the typical challenges in asserting patent rights over chemical compounds like those in WO2007048219?
Chemical patents face hurdles such as navigating complex prior art to demonstrate novelty and inventive step, framing claims broad enough to prevent easy design-arounds, and maintaining patent strength through continuous prosecution and claims amendments.
2. How does the patent landscape influence drug development decisions?
A crowded patent landscape can restrict manufacturing and commercialization avenues, necessitating careful FTO analyses. Innovators may choose to develop novel derivatives or alternative formulations to circumvent existing patents.
3. Can the scope of claims in WO2007048219 impact generic drug entry?
Yes. Broad claims can delay generic entry via patent infringement litigation, whereas narrow claims might allow competitors to develop around the patent more easily.
4. How important is geographic patent protection for drugs related to WO2007048219?
Patent rights are territorial; securing patent protection in key markets (e.g., US, EU, Japan) is crucial for exclusivity and recouping R&D investments, especially given the patent's filing and publication dates.
5. What strategies can patent holders pursue to strengthen the value of patents like WO2007048219?
Innovators should pursue follow-up patents (e.g., patents on additional formulations, methods, or new indications), enforce claims through litigation when infringed, and maintain patent families across multiple jurisdictions.
References
- World Intellectual Property Organization. WO2007048219. Title of the Patent Application.
- Patent landscape reports for chemical compounds in therapeutic areas, e.g., databases such as PatSeer, Derwent, or PatBase.
- Patent law guidelines for pharmaceutical patents, including FDA and EPO criteria for patentability.
- Relevant case law on chemical patent validity and infringement, e.g., G. A. S. H. S. v. G. D. K. (hypothetical citation).
- Industry reports highlighting patent trends in pharmaceutical innovations.
(Note: Specific details such as the exact chemical name, therapeutic indications, and applicant information require access to WO2007048219's full text.)
